https://pbs.twimg.com/media/FhhSOcTXgAAMx9G.png
Fleischmann et al. Safety of TYK2i Deucravacitinib in PsA/PsO in terms of labs. Really no effect on lab values other than increase in trigs. Guess this is why they don't have lab monitoring on label? @RheumNow #ACR22 Abstr#2132 https://t.co/ueIVKQc6jr https://t.co/u99QE71VQ5

Links:

Safety of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor: As A… https://acrabstracts.org/abstract/safety-of-deucravacitinib-an-oral-selective-t…
Richard Conway
RichardPAConway
14-11-2022
×